A team led by Professor Manuel Vázquez-Carrera, from the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine (IBUB) of the UB, has conducted a review study on the Growth Differentiation Factor 15 (GDF15) —a protein expressed under physiological stress conditions— and its potential impact on the treatment for type 2 diabetes. The study, published in the journal Trends in Endocrinology and Metabolism, gathers the most recent research studies on the functioning of this cytokine, which consolidate it as a potential therapeutic target against this disease.

More